Abstract: The present invention relates to a device for regenerating nerve cells and suppressing immune diseases, and more particularly, to a device for regenerating nerve cells and suppressing immune diseases, which uses a contact lens containing a conductive material to increase the effect of microcurrent on nerve cell regeneration and immune response suppression. The device for regenerating nerve cells and suppressing immune diseases comprises: a contact lens comprising a body configured to be worn on a cornea, and a conductive material inserted into the body and serving to induce a microcurrent generated outside the body; a plurality of channels configured to come into close contact with skins around eyes and to generate a flow of microcurrent on upper part of the contact lens; and a signal supply unit configured to supply electrical signals to the plurality of channels.

Abstract: A coil component is provided. The coil component includes a body having fifth and sixth surfaces opposing each other, first and second surfaces respectively connecting the fifth and sixth surfaces of the body and opposing each other, and third and fourth surfaces respectively connecting the first and second surfaces of the body and opposing each other in one direction, a recess disposed in an edge between one of the first and second surfaces of the body and the sixth surface of the body, a coil portion disposed inside the body and exposed through the recess, and an external electrode including a connection portion disposed in the recess and connected to the coil portion, and a pad portion disposed on one surface of the body. A length of the pad portion in the one direction is greater than a length of the connection portion in the one direction.

Abstract: An automatic malignant code collecting system comprises a first database configured to store detection target website information, a virtual machine controller configured to read the website information from the first database and transmit the website information, a first virtual machine configured to periodically gain access to a website using the website information and to collect a malignant code and evidence thereof if an abnormal event occurs when the first virtual machine gains access to the website, a second virtual machine configured to periodically gain access to the same website as accessed by the first virtual machine using the website information received from the virtual machine controller and to collect a malignant code and evidence thereof if an abnormal event occurs when the second virtual machine gains access to the website, and a second database configured to store the malignant code and the evidence thereof collected by the first virtual machine and the second virtual machine.

Abstract: An automatic malignant code collecting system comprises a first database configured to store detection target website information, a virtual machine controller configured to read the website information from the first database and transmit the website information, a first virtual machine configured to periodically gain access to a website using the website information and to collect a malignant code and evidence thereof if an abnormal event occurs when the first virtual machine gains access to the website, a second virtual machine configured to periodically gain access to the same website as accessed by the first virtual machine using the website information received from the virtual machine controller and to collect a malignant code and evidence thereof if an abnormal event occurs when the second virtual machine gains access to the website, and a second database configured to store the malignant code and the evidence thereof collected by the first virtual machine and the second virtual machine.